NPI: 1083667323 · WATSONVILLE, CA 95076 · Community Health Clinic/Center · NPI assigned 05/18/2006
Authorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
| Authorized Official | MOTSIFF, TOM (CFO) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: MOTSIFF, TOM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,445 | $1.13M |
| 2019 | 9,406 | $524K |
| 2020 | 9,959 | $431K |
| 2021 | 17,156 | $1.02M |
| 2022 | 13,715 | $702K |
| 2023 | 17,989 | $959K |
| 2024 | 12,533 | $545K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11,296 | 10,583 | $737K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 727 | 725 | $626K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 764 | 764 | $509K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5,960 | 5,687 | $458K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5,533 | 5,365 | $339K |
| J3490 | Unclassified drugs | 8,760 | 7,420 | $332K |
| S4993 | Contraceptive pills for birth control | 2,369 | 2,352 | $294K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,966 | 1,963 | $271K |
| 87806 | 8,292 | 7,301 | $205K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5,786 | 5,641 | $202K |
| 11981 | 783 | 780 | $197K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 162 | 162 | $168K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 608 | 605 | $131K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 452 | 452 | $111K |
| 11976 | 1,345 | 698 | $91K | |
| 58300 | 717 | 367 | $80K | |
| 99201 | 838 | 837 | $68K | |
| 90837 | Psychotherapy, 53 minutes with patient | 586 | 309 | $56K |
| A4267 | Contraceptive supply, condom, male, each | 3,765 | 3,741 | $51K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 3,833 | 2,849 | $48K |
| S0190 | Mifepristone, oral, 200 mg | 723 | 723 | $43K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 372 | 358 | $32K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,400 | 1,387 | $30K |
| 99000 | 6,641 | 6,487 | $23K | |
| 81025 | 7,058 | 6,913 | $21K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 25 | 25 | $21K |
| 99401 | 1,015 | 999 | $19K | |
| 58301 | 506 | 262 | $17K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 105 | 105 | $14K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 3,666 | 3,582 | $14K |
| 83986 | 4,283 | 3,833 | $13K | |
| 90686 | 598 | 598 | $12K | |
| 90651 | 53 | 53 | $12K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 12 | 12 | $9K |
| 99402 | 267 | 267 | $8K | |
| S5000 | Prescription drug, generic | 1,163 | 1,104 | $8K |
| 90682 | 118 | 117 | $6K | |
| 11982 | 29 | 29 | $5K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 302 | 271 | $5K |
| Q3014 | Telehealth originating site facility fee | 204 | 118 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 39 | 39 | $3K |
| S0191 | Misoprostol, oral, 200 mcg | 875 | 869 | $3K |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 218 | 126 | $3K |
| 90688 | 125 | 125 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,065 | 1,063 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,065 | 1,063 | $2K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 356 | 332 | $2K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 155 | 155 | $2K |
| 81002 | 1,064 | 1,031 | $2K | |
| 92551 | 70 | 70 | $2K | |
| 90630 | 65 | 65 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 13 | 13 | $1K |
| 85018 | 498 | 489 | $1K | |
| 90685 | 46 | 45 | $828.00 | |
| 90832 | Psychotherapy, 30 minutes with patient | 16 | 12 | $666.56 |
| 90715 | 16 | 16 | $462.20 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 25 | 24 | $153.34 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 27 | 26 | $130.93 |
| 3078F | 194 | 193 | $0.00 | |
| 3074F | 189 | 188 | $0.00 |